Kisqali
| Package | Price | Savings |
|---|
| Active Ingredient | Ribociclib |
| Packaging Type | tablet |
| Quantity per Package | 21 |
| Price of Kisqali | From CAD 107,15 per tablet |
| Dosage | 200mg |
| Sale of Kisqali | without prescription |
In our online pharmacy, you can purchase Kisqali without a prescription. We guarantee a seamless purchasing experience by providing access to high-quality medication in an easy and confidential manner.
While Kisqali is generally effective, it’s possible that it may not work for some patients due to individual variations in response to treatment.
No, the contents of your order with Kisqali are strictly confidential. All orders are securely packaged without any external labeling that could reveal the contents, ensuring absolute discretion. We prioritize the privacy of our customers, and no third party will be informed of the details of your order.
Kisqali is a prescription medication used to treat certain types of breast cancer. It works by blocking specific proteins that allow cancer cells to grow and divide, helping to slow down or stop the progression of the disease.
Kisqali is approved for use in Canada for the treatment of certain types of breast cancer in postmenopausal women, and it is available with a prescription from a licensed healthcare professional.
Kisqali (ribociclib) is a CDK4/6 inhibitor that blocks the activity of CDK4 and CDK6 enzymes, which regulate cell division and growth. By inhibiting these enzymes, Kisqali helps slow down the progression of hormone receptor-positive, HER2-negative breast cancer.
Kisqali typically begins working within a few weeks, but it may take up to 2-3 months to see the full effects on slowing or stopping the growth of breast cancer cells.
Kisqali works as long as you continue taking it. It should not be taken for more than 28 days in a row.
Kisqali may cause serious side effects such as lung problems, liver problems, and low white blood cell counts. It should be used as prescribed and under medical supervision.
Kisqali (ribociclib) has an approximate half-life of 32 hours and is eliminated from the body within 7-8 days after the last dose.
Kisqali (ribociclib) is a prescription medication used to treat certain types of breast cancer. It should not cause a positive result on standard drug screening tests.
Here’s the requested output in English:
Kisqali can interact with:
– Antifungals (e.g., ketoconazole)
– Antibiotics (e.g., erythromycin)
– Anti-seizure medications (e.g., carbamazepine)
Contact our support for more details about potential interactions.
Although moderate alcohol consumption is generally not prohibited when taking Kisqali (Ribociclib), it’s always best to consult your healthcare provider. They can offer personalized advice based on your overall health condition, medication dosage, and potential risks of interactions.
Kisqali (ribociclib) should be taken once daily with or without food, in a 21-day cycle. The recommended starting dose is 600 mg (three 200 mg tablets) taken orally.
| How to Take Kisqali: |
|---|
| – Take once daily, with or without food |
| – Follow a 21-day cycle |
| – Recommended starting dose: 600 mg (three 200 mg tablets) |
Kisqali can be prescribed for long-term use in combination with other medications for the treatment of advanced or metastatic breast cancer in postmenopausal women.
In the rare event of an overdose of Kisqali, it is generally not considered potentially fatal. However, it’s important to seek appropriate medical assistance. If you suspect an overdose, you should:
Remember, prompt action is crucial for effectively managing the situation without unnecessary alarms.
Kisqali (ribociclib) is a cyclin-dependent kinase 4/6 inhibitor used in combination with an aromatase inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer in postmenopausal women. It differs from the other medications listed, which include an antiandrogen (flutamide), an antidiabetic (metformin), an antihypertensive (clonidine), and a combination eye drop for glaucoma (Xalacom).
Unlike the other drugs mentioned, Kisqali targets specific cell cycle pathways involved in cancer cell proliferation, making it a targeted therapy for certain types of breast cancer. Its mechanism of action and therapeutic indications set it apart from the comparators, which are used for different conditions and have distinct mechanisms of action.
Kisqali is a prescription medication used to treat advanced or metastatic breast cancer. It’s important to discuss potential side effects, drug interactions, and dosing instructions with your healthcare provider before starting treatment.
Kisqali (ribociclib) should not be used in patients with severe hepatic impairment or in pregnancy. Contraindications include hypersensitivity to the active ingredient or excipients, and lactation. Caution is advised in patients with impaired renal or hepatic function, and in concomitant use with strong CYP3A4 inhibitors or inducers.
Kisqali (ribociclib) is a prescription medication used to treat certain types of breast cancer. Some possible side effects include low white blood cell counts, nausea, fatigue, and hair thinning. Here is a marked list of potential side effects:
It’s important to discuss all potential side effects with your healthcare provider, as they can help manage and mitigate any adverse reactions.
Kisqali is a prescription medication that may impact certain lifestyle aspects like diet and physical activity; consult with your healthcare provider for personalized guidance.
Mental state can potentially influence the effectiveness of Kisqali. Factors like stress, anxiety, and depression may impact medication adherence and overall treatment outcomes. A positive mindset and proper support can aid in managing side effects and promoting treatment success.
Consult a doctor before starting treatment with Kisqali. Your doctor will assess your medical condition and determine if Kisqali is appropriate for you. It’s also important to inform your doctor about any other medications you’re taking, as well as any pre-existing conditions, to avoid potential interactions or complications.
In our pharmacy, Kisqali is available at the most competitive price, ensuring you the best value compared to other suppliers. While other stores may offer quality, our exclusive deals ensure you get premium medication without overpaying. Buy from us and experience the perfect blend of affordability and reliable quality.
Kisqali is available for delivery in the following cities in Canada:
| City | Province | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-9 days |
| Calgary | Alberta | 5-9 days |
| Edmonton | Alberta | 5-9 days |
| Ottawa | Ontario | 5-9 days |
| Winnipeg | Manitoba | 5-9 days |
| Quebec City | Quebec | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
For additional locations and delivery inquiries, please contact our support team.
